Fundraising Fox
Hermes Biosciences
3 known investors
Find your way into Hermes Biosciences
Sign up to see every warm intro you have to Hermes Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hermes Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
Investors · 3
GENERAL INCEPTIONlisted by GENERAL INCEPTIONPalo Alto
How we know: GENERAL INCEPTION's portfolio page · Not right? Tell us
Paladin Capital Grouplisted by Paladin Capital GroupWashington · $100K – $5M
How we know: Paladin Capital Group's portfolio page · Not right? Tell us
Genoa VenturesreportedSan Francisco
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does Hermes Biosciences do?
- Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
- Who are Hermes Biosciences's investors?
- Hermes Biosciences's investors include GENERAL INCEPTION, Paladin Capital Group, Genoa Ventures.